Stephen Langabeer

43PUBLICATIONS
3CO-AUTHORS
Haematological tumoursImmunogenetics (incl. genetic immunology)Medical biochemistry - nucleic acidsHaematologyMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Jun 25, 2026
Molecular screening for myeloproliferative neoplasms in young patients with stroke.

|Feb 04, 2026
Should JAK2 V617F Mutation Testing be Inducted into Routine Thrombophilia Screening?

Stephen E Langabeer

|Nov 01, 2025
Langerhans cell sarcoma and myeloproliferative neoplasms: close or distant relatives?

Stephen E Langabeer

|Mar 12, 2025
Elevated lactate dehydrogenase and reflexive myeloproliferative neoplasm molecular diagnostics.

Stephen E Langabeer

|Aug 20, 2024
Clonal Hematopoiesis from a Diagnostic Perspective: 10 Years of CHIP.

Lasse Kjær, Vibe Skov, Morten Kranker Larsen

|May 21, 2024
Incidence and impact of non-canonical JAK2 p.(Val617Phe) mutations in myeloproliferative neoplasm molecular diagnostics.

Danielle Patchell, Clodagh Keohane, Susan O'Shea

Pageof 8

Frequent Collaborators

3 joint publications

Karl Haslam

2 joint publications

David O'Brien

1 joint publications

Lasse Kjær